• Borie A, Chetboul V
  • PV 229
  • Octobre 2002

Pour en savoir plus
- Principaux régulateurs de la génération de thrombine in vivo ;
- Schéma de l'hémostase secondaire in vivo (sans les régulateurs).


Bibliographie

1. Adams HR. Hemostatic and anticoagulant drugs. In: Veterinary Pharmacology and Therapeutics. 6th ed. Ames, Iowa Staste University Press, 1988:482-494.
2. Agnelli G. Pharmacological activities of heparin chains: should our past knowledge be revised? Haemostasis, 1996;26(suppl 2):2-9.
3. Baty CJ, Hardie EM. Pulmonary thromboembolism: diagnosis and treatment. In: Current Veterinary Therapy XI Small Animal Practice. Philadelphia, WB Saunders, 1992:137-142.
4. Behrend EN, Grauer GF, Greco DS et coll.. Comparison of the effects of diltiazem and aspirin on platelet aggregation in cats. J. Amer. Anim. Hosp. Assn. 1996;32:11-18.
5. Boothe DM. Prostaglandins: physiology and clinical implications. Comp. Cont. Educ. Pract. Vet. 1984;6(11):1010-1021.
6. Boothe DM. Drugs acting on blood and/or blood-forming organs. Vet. Clin. N. Amer.-Small Anim. Pract. 1998;3:329-360.
7. Boudreaux MK. Platelets and coagulation. An update. Vet. Clin. N. Amer.-Small Anim. Pract. 1996;26(5):1065-1086.
8. Carr AP, Jonnson GS. A review of hemostatic abnormalities in dogs and cats. J. Amer. Anim. Hosp. Assn. 1994;30:475-482.
9. Chetboul V, Devauchelle P. Thromboembolie pulmonaire chez les carnivores. Point Vét. 1995;27(n° spécial pathologie respiratoire des carnivores domestiques):463-475.
10. Clements CA, Rogers KS, Green RA et coll. Splenic vein thrombosis resulting in acute anemia: an anusual manifestation of nephrotic syndrome in a chinese Shar Pei with reactive amyloidosis. J. Amer. Anim. Hosp. Assn. 1995;31:411-415.
11. De Gopegui RR, Feldman BF. Use of blood and blood components in canine and feline patients with hemostatic disorders. Vet. Clin. N. Amer.-Small Anim. Pract. 1995;25(6):1387-1403.
12. Dennis JS. The pathophysiologic sequelae of pulmonary thromboembolism. Comp. Cont. Educ. Pract. Vet. 1991;13(12):1811-1818.
13. Dennis JS. Clinical features of canine pulmonary thromboembolism. Comp. Cont. Educ. Pract. Vet. 1993;15(12):1595-1603.
14. Feldman EC, Nelson RW. Hyperadrenocorticism. In Canine and Feline Endocrinology and Reproduction. 2nd ed. Philadelphia, WB Saunders, 1996:187-265.
15. Flückiger MA, Gomez JA. Radiographic findings in dogs with spontaneous pulmonary thrombosis or embolism. Vet. Radiol. 1984;25:124-131.
16. Frydman A. Low-molecular-weight heparins: an overview of their pharmacodynamics, pharmacokinetics and metabolism in humans. Haemostasis. 1996;26(suppl 2):24-38.
17. Green RA. Activated coagulation time in monitoring heparinized dogs. Amer. J. Vet. Res. 1980;41 (11):1793-1797.
18. Green RA. Clinical implications of antithrombin III deficiency in animal diseases. Comp. Cont. Educ. Pract. Vet. 1984;6(6):537-545.
19. Green RA. Pathophysiology of antithrombin III deficiency. Vet. Clin. N. Amer. Small Anim. Pract. 1988;18(1):95-104.
20. Green RA, Thomas JS. Hemostatic disorders: coagulopathies and thrombosis. In: Texbook of Veterinary Internal Medicine. Diseases of the dog and the cat, 4th ed. Philadelphia, WB Saunders, 1995:1946-1963.
21. Greene CE, Meriwether E. Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats. Amer. J. Vet. Res. 1982;43(8):1473-1477.
22. Guelfi JF, Diquelou A. L'exploration biologique de l'hémostase chez le chien. Point Vét. 1995;26(164):755-759.
23. Gurfinkel E, Fareed J, Antman E et coll. Rationale for the management of coronary syndromes with low-molecular-weight heparins. Amer. J. Cardiol. 1998;82(5B):15L-18L.
24. Harpster NK. Feline myocardial diseases. In: Current Veterinary Therapy IX Small Animal Practice. Philadelphia, WB Saunders, 1986:380-398.
25. Kellerman DL, Lewis DC, Myers NC et coll. Determination of a therapeutic heparin dosage in the cat. Proc. Amer. Coll. Vet. Intern. Med.14th. 1996;748.
26. Killingsworth CR, Eyster GE, Adams T et coll. Streptokinase treatement of cats with experimentally induced aortic thrombosis. Amer. J. Vet. Res. 1986;47(6):1351-1359.
27. Larue MJ, Murtaugh RJ. Pulmonary thromboembolism in dogs: 47 cases (1986-1987). J. Amer. Vet. Med. Assn. 1990;197(10):1368-1372.
28. Mac Harg MA, Becht JL. The pharmacology of heparin prophylaxis. J. Amer. Vet. Med. Assn. 1983;183(1):129-130.
29. Massignon D. Cours d'hémobiologie DCEM1. Faculté de médecine de Lyon Nord, 1998.
30. Mischke R, Grebe S, Jacobs C et coll. Amidolytic heparin activity and values for several hemostatic variables after repeated subcutaneous administration of high doses of a low molecular weight heparin in healthy dogs. Amer. J. Vet. Res. 2001;62(4):595-598.
31. Palmer KG, King LG, Van Winkle TJ. Clinical manifestations and associated disease syndromes in dogs with cranial vena cava thrombosis: 17 cases (1989-1996). J. Amer. Vet. Med. Assn., 1998;213(2):220-224.
32. Rackear D, Feldman B, Farver T et coll. The effect of three different dosages of acetylsalicylic acid on canine platelet aggregation. J. Amer. Anim. Hosp. Assn. 1988;24:23-26.
33. Rackear DG. Drugs that alter the hemostatic mechanism. Vet. Clin. N. Amer.-Small Anim. Pract. 1988;18(1):67-76.
34. Rawlings CA, Calvert CA. Heartworm disease. In: Texbook of Veterinary Internal Medicine. Diseases of the dog and the cat. 4th ed. Philadelphia, WB Saunders, 1995:1046-1068.
35. Sisson DD, Thomas WP. Myocardial diseases. In: Texbook of Veterinary Internal Medicine. Diseases of the dog and the cat. 4th ed. Philadelphia, WB Saunders, 1995:995-1032.
36. Suter PF, Fox PR. Peripheral vascular disease. In: Texbook of Veterinary Internal Medicine. Diseases of the dog and the cat. 4th ed. Philadelphia, WB Saunders, 1995:1068-1081.
37. Szucs G, Miko I, Ajzner E et coll. Efficacy of prevention of thromboembolic complications with LMW-heparin in experiment. Acta Chir. Hung. 1997;36(1-4):356-358.
38. Thomas JS, Green RA. Clotting time and antithrombin III activity in cats with naturally developing diseases : 85 cases (1984-1994). J. Amer. Vet. Med. Assn. 1998;213(9):1290-1295.
39. Troy GC. An overview of hemostasis. Vet. Clin. N. Amer.-Small Anim. Pract. 1988;18(1):5-20.
40. Van Winkle TJ, Bruce E. Thrombosis of the portal vein in eleven dogs. Vet. Pathol. 1993;30:28-35.
41. Van Winkle TJ, Hackner SG, Liu SM. Clinical and pathological features of aortic thromboembolism in 36 dogs. Journal of Veterinary Emergency and Critical Care. 1993;3(1):13-21.
42. Verhaeghe R. The use of low-molecular-weight heparins in cardiovascular disease. Acta Cardiol. 1998;53(1):15-21.
43. Welles EG. Antithrombotic and fibrinolytic factors. Vet. Clin. N. Amer.-Small Anim. Pract. 1996;26(5):1111-1127.
44. Williamson LH. Antithrombin III: a natural anticoagulant. Comp. Cont. Educ. Pract. Vet. 1991;13(1):100-107.


En poursuivant votre navigation sur ce site, vous acceptez l’utilisation de cookies pour vous proposer des services et offres adaptés à vos centres d’intérêts.X
Pour en savoir plus et paramétrer les cookies...